caprazamycins (Meiji Seika)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namecaprazamycins (Meiji Seika)
Drug Alias Nameantimycobacterials (Meiji Seika Kaisha)caprazolcaprazeneCaprazamycin Bmycobacterial infection therapeutic (Meiji Seika Kaisha) +[9] 
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMycobacterium Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMeiji Seika Pharmatech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeiji Seika Pharmatech Co Ltd
Active IndicationsN/A
Inactive IndicationsMycobacterium Infections

Other Information

ATC CodeN/A
Related LinksN/A